Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Susan E. Dorman et al.|Clinical Infectious Diseases|2016Cited by 1.5k
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Susan E. Dorman et al.|Clinical Infectious Diseases|2016Cited by 321
Revisiting Rates of Reactivation Tuberculosis: A Population-based ApproachC. Robert Horsburgh, C. Fordham von Reyn, Max R. O’Donnell et al.|American Journal of Respiratory and Critical Care Medicine|2010Cited by 144
Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials ConsortiumSusan E. Dorman, Neil W. Schluger, Stefan Goldberg et al.|The Journal of Infectious Diseases|2012Cited by 110